Webinar

Understanding the relevance of the Orphan Drug-Regulation within AMNOG for patient care

Thursday, 6, February, 2025
Orphan Drug-Regulation

With the evolution of AMNOG-regulations, Germany has emerged as one of the most complex healthcare markets globally from a pricing and market access (P&MA) perspective. While Orphan Drugs (ODs) currently receive certain protections under the AMNOG framework, ongoing health policy debates are raising questions about the potential restriction or elimination of these OD-specific privileges. What would such changes mean for the German healthcare market and the accessibility of these critical therapies?

Our latest report, Relevance of the Orphan Drug-Regulation within AMNOG for Patient Care, reveals that if Germany’s OD-specific protections under AMNOG were removed, more than half of the ODs would face a very high to maximum risk of market withdrawal due to their inability to demonstrate an added benefit, exposing them to dramatic price reductions.


In this episode of our Simon-Kucher Better Market Access webinar series, we will present the findings from our retrospective market simulation analyzing the impact of a hypothetical abolition of this OD-regulation on the risk of market withdrawal of these innovative therapies. In addition, we will highlight important strategic implications for pharma companies to plan and optimize P&MA for their ODs in Germany.

This webinar will explore:

  • Current OD-regulation landscape within AMNOG and its vital role for P&MA
  • Results of a P&MA simulation for the German OD-market without OD-regulation
  • Resulting risk of market withdrawals across different therapeutic areas
  • Strategic recommendations to optimize P&MA success for ODs in Germany

By attending, you will gain actionable insights to prepare your organization for potential regulatory shifts in the P&MA environment for ODs and support patient access to these essential therapies.

Event Details:

Please note, we are offering two identical sessions:

  • February 6th: 02:00 – 03:00 p.m. CET

  • February 6th: 05:00 – 06:00 p.m. CET | 11:00 a.m. – 12:00 p.m. EST | 08:00 - 09:00 a.m. PST

This webinar is free of charge. Don’t miss this opportunity to learn from industry experts about the evolving relevance of OD regulations and how to strategically optimize P&MA success in Germany.

Event details
  • Webinar
  • 1. Session
  • Thu, February 6, 2025
  • 14:00 - 15:00 CET |
    17:00 - 18:00 +04
  • 2. Session
  • Thu, February 6, 2025
  • 17:00 - 18:00 CET |
    11:00 - 12:00 EST

Speakers

Partner
ドイツ・ミュンヘン
Partner
ドイツ・ミュンヘン

Contact

Looking for more information or questions about the event?